歐扶篤錠 {KYO OFUTO TABLETS} @ 藥要看

許可證字號: 衛署藥輸字第005273號
註銷狀態: 已註銷
註銷日期: 1992-11-11
註銷理由: 有效期間已屆未能補件
有效日期: 1991-07-23
發證日期: 1977-07-29
許可證種類: 製　劑
舊證字號: 13005770
通關簽審文件編號: DHA00200527301
中文品名: 歐扶篤錠
英文品名: KYO OFUTO TABLETS
藥品類別: 06須由醫師處方使用
管制藥品分類級別: 無紀錄
主成分略述: SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE), METHIONINE DL-, BIOTAMYLASE, CINNAMON OIL (OLEUM CINNAMOMI), ALOE POWDER (EQ TO POWDERED ALOE), GENTIAN POWDER, PANCREATIN (DIASTASE VERA), CHOLINE BITARTRATE, NUX VOMICA EXTRACT, BENZOCAINE (ETHYL AMINOBENZOATE), GERANIUM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN (VIT B2), SWERTIA POWDER, ALUMINUM SILICATE, CARMELLOSE SODIUM (CMC SOD.)(CELLULOSE GUM SOD.), DEHYDROACETIC ACID
申請商名稱: 高平貿易股份有限公司
申請商地址: 台北市錦州街２８６號
申請商統一編號: 11550305
製造商名稱: KOBAYASHI PHARMACEUTICAL INDUSTRIAL CO. LTD.
製造廠廠址: 7-6, OIMAZATE 2-CHOME HIGASHINARI-KU OSAKA
製造廠公司地址: 無紀錄
製造廠國別
製程: 無紀錄
其他製造商: KOBAYASHI PHARMACEUTICAL INDUSTRIAL CO. LTD.
KOBAYASHI
異動日期: 2001-12-30
資料更新時間: 2020-02-25 08:36:12
國際條碼: 無紀錄
健保代碼: 無紀錄

處方標示	成分名稱	含量	單位
EACH TABLET CONTAINS:	SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE)	138.8888	MG
EACH TABLET CONTAINS:	ALUMINUM SILICATE	55.5555	MG
EACH TABLET CONTAINS:	CARMELLOSE SODIUM (CMC SOD.)(CELLULOSE GUM SOD.)	38.8888	MG
EACH TABLET CONTAINS:	GENTIAN POWDER	22.2222	MG
EACH TABLET CONTAINS:	PANCREATIN (DIASTASE VERA)	16.6666	MG
EACH TABLET CONTAINS:	BENZOCAINE (ETHYL AMINOBENZOATE)	11.1111	MG
EACH TABLET CONTAINS:	BIOTAMYLASE	5.5555	MG
EACH TABLET CONTAINS:	ALOE POWDER (EQ TO POWDERED ALOE)	5.5555	MG
EACH TABLET CONTAINS:	SWERTIA POWDER	5.5555	MG
EACH TABLET CONTAINS:	GERANIUM	5.5555	MG
EACH TABLET CONTAINS:	CHOLINE BITARTRATE	3.3333	MG
EACH TABLET CONTAINS:	METHIONINE DL-	1.6666	MG
EACH TABLET CONTAINS:	NUX VOMICA EXTRACT	1.6666	MG
EACH TABLET CONTAINS:	DEHYDROACETIC ACID	0.2777	MG
EACH TABLET CONTAINS:	THIAMINE HYDROCHLORIDE	0.1666	MG
EACH TABLET CONTAINS:	CINNAMON OIL (OLEUM CINNAMOMI)	0.1111	MG
EACH TABLET CONTAINS:	RIBOFLAVIN (VIT B2)	0.0555	MG